The use of globotriaosylsphingosine to detect and monitor Fabry disease
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by a deficiency of the α-galactosidase-A (α-gal-A) enzyme. The lack of enzymatic activity results in the accumulation of glycosphingolipids (GSLs) in the lysosomes of various tissues and organs. Globotriaosylceramide (Gb3) and Globo...
Main Author: | Alharbi, Fahad Jazza |
---|---|
Published: |
University of Birmingham
2016
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.694738 |
Similar Items
-
The role of gastrin in the development of gastric preneoplastic and neoplastic changes
by: Murugesan, Senthil
Published: (2012) -
Optimizing the use of capsule endoscopy in the detection of small-bowel pathology
by: Koulaouzidis, Anastasios
Published: (2014) -
Optimising the use of Azathioprine in the treatment of Inflammatory Bowel Disease
by: Smith, Melissa Ann
Published: (2016) -
Development and use of cell models to investigate McArdle disease
by: Wright, Kathryn Elizabeth
Published: (2009) -
Pharmacogenetic markers of response to drugs used in the management of Inflammatory Bowel Disease
by: Baburajan, Bijay
Published: (2012)